Ayurvedic and Herbal Medicines With Targeted Therapy: — The Real Risks

The honest answer is that it depends on the specific herb, the specific drug, and the dose — and many combinations have not been studied well enough to give a confident answer. ASCO and NCCN guidance recommends disclosing every supplement to your oncology team before taking it, not because Ayurvedic medicine is dismissed, but because the liver interactions are real and can shift your drug level in ways that affect both safety and effectiveness. Your team cannot advise you without knowing what you are taking.

Culinary turmeric used in cooking reaches very different levels in the body compared to a concentrated curcumin capsule. The concern with supplements is the dose: a capsule can deliver a concentration that food simply does not. At those levels, curcumin inhibits the CYP3A4 enzyme your liver uses to process your targeted therapy drug. If you are taking turmeric in food, that is generally a different matter — but mention it to your team anyway. The question is specifically about supplements and concentrated extracts.

If a herb induces CYP3A4, your liver clears the drug faster than intended. The level in your blood falls below what your oncologist calculated as effective. You may continue taking the tablet every day and feel no different, while the drug is not reaching the concentration needed to act on the cancer. This is one reason drug interactions are taken seriously even when you feel well: the consequence is not always an obvious side effect — sometimes it is simply the treatment not working.

If a herb inhibits CYP3A4, the drug is cleared more slowly and builds up above the intended level. Side effects that were mild at the calibrated dose can become more severe — skin reactions, diarrhoea, liver strain, and fatigue are common with many targeted therapies at higher exposures. Your oncologist has chosen your dose to balance effectiveness against side effects; a herb that shifts that balance upward changes the calculation without anyone knowing it has happened.

Do not stop abruptly without telling your team first. Stopping an inducer suddenly — a herb that was speeding up CYP3A4 — can cause the drug level to rise sharply once that effect is removed, which carries its own risks. Tell your oncologist what you have been taking and for how long, and let them advise on whether to stop, how quickly, and whether any monitoring is needed. An honest conversation now is safer than a sudden change in either direction.

A responsible oncologist will not. What matters clinically is that they know, so they can review for interactions and advise you safely. Many people use traditional remedies alongside cancer treatment, and the conversation is common. What is genuinely unhelpful is discovering an interaction after something has changed — drug levels, side effects, or scan results — without knowing the cause. You are not being asked to stop; you are being asked to disclose, so both parts of your care can be managed together.

The evidence base for most individual herbs in combination with targeted therapies is still limited, which is why a blanket clearance for any preparation is not something that can be given here. Some herbs have fewer documented interactions than others, but that also reflects how little they have been studied rather than confirmed safety. Bring a complete list to your next appointment — the herb name, the brand if it is a product, the dose, and how often you take it. That is the conversation that produces a safe answer for your specific drug.

A weak infusion used occasionally is unlikely to reach the concentrations seen with capsules or extracts. But some teas — particularly those made with large quantities of herb, or consumed several times a day — can deliver meaningful amounts of active compounds. Teas made from St John's Wort carry the same caution as the capsule form. Tell your team what you drink regularly, not only what you take as a tablet or capsule. The distinction between food-level and supplement-level exposure is a question of dose, and your team can help you assess it.